Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.710
+0.010 (1.43%)
Mar 6, 2026, 3:45 PM EST

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
8131360145143
Upgrade
Market Cap Growth
-23.68%-3.18%-77.69%-58.70%1.59%47.63%
Upgrade
Enterprise Value
8141557123116
Upgrade
Last Close Price
0.712.274.0924.6060.0067.87
Upgrade
PB Ratio
-1.02-1.67-2.75-19.887.504.03
Upgrade
P/TBV Ratio
----7.514.03
Upgrade
Debt / Equity Ratio
-0.06-0.13-0.26-1.360.260.20
Upgrade
Net Debt / Equity Ratio
-0.05-0.110.01-0.37-0.88-0.98
Upgrade
Net Debt / EBITDA Ratio
-0.04-0.070.00-0.040.701.10
Upgrade
Net Debt / FCF Ratio
-0.06-0.090.00-0.060.640.98
Upgrade
Quick Ratio
0.010.030.170.353.513.76
Upgrade
Current Ratio
0.060.040.240.353.693.85
Upgrade
Return on Equity (ROE)
----297.38%-89.25%-273.75%
Upgrade
Return on Assets (ROA)
-400.07%-241.99%-211.70%-82.24%-38.09%-68.53%
Upgrade
Return on Capital Employed (ROCE)
142.60%163.60%596.90%7112.30%-106.90%-79.20%
Upgrade
Earnings Yield
-138.44%-89.78%-128.57%-40.51%-16.85%-22.27%
Upgrade
FCF Yield
--70.23%-153.13%-32.29%-18.33%-24.90%
Upgrade
Buyback Yield / Dilution
-78.11%-74.87%-17.99%-0.91%-21.22%-36.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.